Accenture (NYSE: ACN) has agreed to acquire consus.health, a
leading German healthcare management consultancy. consus.health
offers services ranging from medical strategy and patient
management to procurement and logistics, infrastructure management
and construction planning services. By adding consus.health’s
strategy and industry consulting skills to its capabilities in
digital transformation and managed services, Accenture will enhance
its ability to help healthcare providers and hospitals across
Germany, Austria and Switzerland improve their quality of care.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240820016192/en/
Accenture has agreed to acquire
consus.health, a leading German healthcare management consultancy.
(Photo: Business Wire)
Founded in 2012, consus.health has a strong presence in the
German market serving more than 600 healthcare providers and
hospitals. With a deep strategy and industry consulting know-how
and a strong industry network in the healthcare market,
consus.health has built a track record in improving the financial
and operational performance of its clients. Their services include
streamlining operations and enhancing both strategy and financial
management to help clients manage costs and protect revenues. They
also advise on improving the infrastructure, logistics and energy
efficiency of hospitals as well as on optimizing their
construction. Part of their portfolio is the consus healthcare
akademie that offers more than 90 training courses for all levels
of healthcare professionals. Headquartered in Freiburg im Breisgau,
consus.health’s team of 140 experts will join Accenture’s Health
Strategy & Consulting practice in Germany.
“In the healthcare industry, organizations are under pressure to
improve access, experience and outcomes, while reducing costs,”
said Christina Raab, market unit lead for Accenture in Austria,
Switzerland and Germany. “consus.health’s industry expertise will
enhance our capabilities that help healthcare organizations with
their digital transformation journeys and drive efficiency at the
same time.”
“The acquisition of consus.health is a significant milestone in
our strategy to serve clients end-to-end in an expanding healthcare
market,” said Katharina Michaelis, Accenture’s social services and
health portfolio lead for Germany. “consus.health’s expertise in
revenue and cost management, process optimization, and hospital
management will complement our existing offerings and enable us to
provide our clients with even more comprehensive solutions.”
“By joining Accenture, we will continue our mission of
structurally and economically empowering healthcare organizations
to care for their patients,” said Dr Djordje Nikolic, founder and
CEO of consus.health. “I am convinced that with Accenture's digital
expertise and consus.health's healthcare know-how, we will help
make a difference in healthcare and offer exciting new
opportunities to our employees.” Nikolic will lead Accenture’s
Health Strategy & Consulting practice in Austria, Switzerland
and Germany and will be responsible to build-up and grow the health
provider business.
The acquisition of consus.health is the latest in a series of
strategic investments that Accenture has made to position itself as
a leading provider of consulting, digital transformation and
managed services in the healthcare sector including Intellera
Consulting, ConcentricLife and Nautilus Consulting.
Terms of the transaction were not disclosed. Completion of the
acquisition is subject to customary closing conditions.
Forward-Looking Statements
Except for the historical information and discussions contained
herein, statements in this news release may constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Words such as “may,”
“will,” “should,” “likely,” “anticipates,” “aspires,” “expects,”
“intends,” “plans,” “projects,” “believes,” “estimates,”
“positioned,” “outlook,” “goal,” “target” and similar expressions
are used to identify these forward-looking statements. These
statements are not guarantees of future performance nor promises
that goals or targets will be met, and involve a number of risks,
uncertainties and other factors that are difficult to predict and
could cause actual results to differ materially from those
expressed or implied. These risks include, without limitation,
risks that: Accenture and consus.health will not be able to close
the transaction in the time period anticipated, or at all, which is
dependent on the parties’ ability to satisfy certain closing
conditions; the transaction might not achieve the anticipated
benefits for Accenture; Accenture’s results of operations have
been, and may in the future be, adversely affected by volatile,
negative or uncertain economic and political conditions and the
effects of these conditions on the company’s clients’ businesses
and levels of business activity; Accenture’s business depends on
generating and maintaining client demand for the company’s services
and solutions including through the adaptation and expansion of its
services and solutions in response to ongoing changes in technology
and offerings, and a significant reduction in such demand or an
inability to respond to the evolving technological environment
could materially affect the company’s results of operations; if
Accenture is unable to match people and their skills with client
demand around the world and attract and retain professionals with
strong leadership skills, the company’s business, the utilization
rate of the company’s professionals and the company’s results of
operations may be materially adversely affected; Accenture faces
legal, reputational and financial risks from any failure to protect
client and/or company data from security incidents or cyberattacks;
the markets in which Accenture operates are highly competitive, and
Accenture might not be able to compete effectively; Accenture’s
ability to attract and retain business and employees may depend on
its reputation in the marketplace; if Accenture does not
successfully manage and develop its relationships with key
ecosystem partners or fails to anticipate and establish new
alliances in new technologies, the company’s results of operations
could be adversely affected; Accenture’s profitability could
materially suffer if the company is unable to obtain favourable
pricing for its services and solutions, if the company is unable to
remain competitive, if its cost-management strategies are
unsuccessful or if it experiences delivery inefficiencies or fail
to satisfy certain agreed-upon targets or specific service levels;
changes in Accenture’s level of taxes, as well as audits,
investigations and tax proceedings, or changes in tax laws or in
their interpretation or enforcement, could have a material adverse
effect on the company’s effective tax rate, results of operations,
cash flows and financial condition; Accenture’s results of
operations could be materially adversely affected by fluctuations
in foreign currency exchange rates; changes to accounting standards
or in the estimates and assumptions Accenture makes in connection
with the preparation of its consolidated financial statements could
adversely affect its financial results; as a result of Accenture’s
geographically diverse operations and strategy to continue to grow
in key markets around the world, the company is more susceptible to
certain risks; if Accenture is unable to manage the organizational
challenges associated with its size, the company might be unable to
achieve its business objectives; Accenture might not be successful
at acquiring, investing in or integrating businesses, entering into
joint ventures or divesting businesses; Accenture’s business could
be materially adversely affected if the company incurs legal
liability; Accenture’s global operations expose the company to
numerous and sometimes conflicting legal and regulatory
requirements; Accenture’s work with government clients exposes the
company to additional risks inherent in the government contracting
environment; if Accenture is unable to protect or enforce its
intellectual property rights or if Accenture’s services or
solutions infringe upon the intellectual property rights of others
or the company loses its ability to utilize the intellectual
property of others, its business could be adversely affected;
Accenture may be subject to criticism and negative publicity
related to its incorporation in Ireland; as well as the risks,
uncertainties and other factors discussed under the “Risk Factors”
heading in Accenture plc’s most recent Annual Report on Form 10-K
and other documents filed with or furnished to the Securities and
Exchange Commission. Statements in this news release speak only as
of the date they were made, and Accenture undertakes no duty to
update any forward-looking statements made in this news release or
to conform such statements to actual results or changes in
Accenture’s expectations.
About Accenture
Accenture is a leading global professional services company that
helps the world’s leading businesses, governments and other
organizations build their digital core, optimize their operations,
accelerate revenue growth and enhance citizen services—creating
tangible value at speed and scale. We are a talent- and
innovation-led company with approximately 750,000 people serving
clients in more than 120 countries. Technology is at the core of
change today, and we are one of the world’s leaders in helping
drive that change, with strong ecosystem relationships. We combine
our strength in technology and leadership in cloud, data and AI
with unmatched industry experience, functional expertise and global
delivery capability. We are uniquely able to deliver tangible
outcomes because of our broad range of services, solutions and
assets across Strategy & Consulting, Technology, Operations,
Industry X and Song. These capabilities, together with our culture
of shared success and commitment to creating 360° value, enable us
to help our clients reinvent and build trusted, lasting
relationships. We measure our success by the 360° value we create
for our clients, each other, our shareholders, partners and
communities. Visit us at www.accenture.com.
Copyright ©2024 Accenture. All rights reserved. Accenture and
its logo are registered trademarks of Accenture.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240820016192/en/
Thomas Wittek Accenture +49 151 52507486
thomas.wittek@accenture.com
Accenture (NYSE:ACN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Accenture (NYSE:ACN)
Historical Stock Chart
From Nov 2023 to Nov 2024